Medical Device News Magazine

Cardiac Insight Comments on CMS Plans to Establish Nationwide Payment for Long-Term ECG Monitoring in 2023

U.S. based cardiac arrhythmia diagnostic medical device system innovator supports CMS Proposed National Payment Framework for Long-Term ECG Monitoring

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, shares its perspective on recent announcements impacting its served markets.

These markets include the exponentially growing Atrial Fibrillation (AF) and the emerging ‘long COVID-19’ cardiac arrhythmia diagnostic market, both of which potentially impact millions of Medicare recipients nationwide.

On July 7, 2022, the Centers for Medicare & Medicaid Services (CMS) released proposed rule changes for payments under the Medicare Physician Fee Schedule (MPFS), and other Medicare Part B issues, effective on or after January 1, 2023. The MPFS proposed rule, subject to a comment period and Final Rule determination later in 2022, includes the long-awaited establishment of a national physician payment rate framework for Long Term ECG (LT-ECG) CPT code sets. LT-ECG code sets support diagnostic ECG testing, most often performed using chest-worn prescription wearables worn from over 2 days to up to 15 days.

Cardiac Insight appreciates this progress by CMS, which affirms the importance of the LT-ECG diagnostic category to aid physicians in timely, accurate diagnosis of potentially devastating cardiac arrhythmias, especially AF. Atrial Fibrillation or ‘AF’ is the most common cardiac arrhythmia worldwide and puts individuals at up to 5X the risk of a disabling stroke, as well as at higher risk of heart failure and sudden cardiac death if left undiagnosed and untreated,” stated Bob Odell, Chief Operating Officer, of Cardiac Insight.

“The proposed MPFS is public recognition of the work physicians perform daily to apply ECG monitors, generate reports, and achieve earlier patient diagnosis and treatment of significant cardiac conditions that can improve Medicare recipient healthcare quality, outcomes and cost-effectiveness. Efficient cardiac arrhythmia diagnosis becomes even more important with the increased incidence of cardiac arrhythmias noted following COVID-19 infection,” continued Odell.

Cardiac Insight’s Cardea SOLO™ 7-day ECG System uniquely provides a provider-centric approach to cardiac arrhythmia detection. Cardea SOLO offers the only complete “in-house and all-inclusive” prescription-based wearable cardiac arrhythmia ECG patch detection system that delivers automated draft analysis at the point of clinical care, with no costly outsourcing. Eliminating ECG services outsourcing reduces a potential source of diagnostic delays and patient data breaches. Outsourcing can also increase costs to patients, payers and healthcare systems compared to the provider-centric approach.

Cardea SOLO ECG is prescribed by cardiologists, internal medicine, adult primary care, and medical specialists working in a variety of healthcare settings around the world.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.